Pricing Log in Create free account

OSR Health, Inc. (OSRH) vs Xenetic Biosciences, Inc. (XBIO)

OSR Health, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. OSR Health, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.4M and $4.1M). Xenetic Biosciences, Inc. grew revenue faster over the last twelve months: 33.3% against −50.2%. Xenetic Biosciences, Inc. has the higher net margin (−75.9% vs −593.2%) and the higher return on invested capital (0.00% vs −8.19%). Across the 17 metrics below, Xenetic Biosciences, Inc. leads on 12 and OSR Health, Inc. on 5.

Valuation

Metric OSRH XBIO Biotechnology median
P/E n/m n/m 10.60
P/S 2.73 1.32 9.40
P/B 0.04 0.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.40 0.66
EV/Sales 4.90 (0.32) 9.02
Earnings yield (264.00%) (64.48%) (32.88%)
Free cash flow yield (154.77%) (53.86%) (23.13%)

Profitability

Metric OSRH XBIO Biotechnology median
Gross margin 35.29% 100.00% 68.51%
Operating margin (933.72%) (81.01%) 0.00%
Net margin (593.21%) (75.90%) 0.00%
Free cash flow margin (398.26%) (70.93%) 0.00%
Return on equity (8.13%) (47.05%) (51.96%)
Return on assets (6.10%) (40.17%) (46.06%)
Return on invested capital (8.19%) 0.00% 0.00%

Growth

Metric OSRH XBIO Biotechnology median
Revenue growth (TTM) (50.24%) 33.30% 6.76%
EPS growth (last fiscal year) 83.31% 38.52% 29.88%
Revenue growth, 5-year CAGR — 46.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OSRH XBIO Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 0.18 7.43 4.97
Net debt to EBITDA (0.29) 2.78 1.01

Dividend

Metric OSRH XBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OSRH XBIO Biotechnology median
Market cap 4.09m 4.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack